Brief: Atea Pharmaceuticals receives notice of director nominations from Bradley Radoff
21/03/2025 21:58
March 21 (Reuters) - Atea Pharmaceuticals Inc AVIR.O: ATEA PHARMACEUTICALS INC - RECEIVES NOTICE OF DIRECTOR NOMINATIONS FROM BRADLEY L. RADOFF ATEA PHARMACEUTICALS: BRADLEY L. RADOFF TO NOMINATE THREE DIRECTOR CANDIDATES TO STAND FOR ELECTION TO CO'S BOARD Source text: ID:nGNX2xshVk Further company coverage: AVIR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM